0,872  0,004  Caspase 9 stimulant
0,863  0,009  Apoptosis agonist
0,854  0,004  CYP1A2 inhibitor
0,851  0,003  Caspase 3 stimulant
0,839  0,005  Antineoplastic (lung cancer)
0,821  0,003  Histamine release inhibitor
0,799  0,009  Antineoplastic (breast cancer)
0,784  0,004  Tubulin antagonist
0,751  0,004  CYP2C19 inhibitor
0,750  0,004  Antineoplastic (carcinoma)
0,734  0,007  Prostate cancer treatment
0,721  0,005  NOS2 expression inhibitor
0,716  0,008  Aryl hydrocarbon receptor agonist
0,720  0,013  Antineoplastic (colorectal cancer)
0,702  0,004  Breast cancer-resistant protein inhibitor
0,709  0,013  Antineoplastic (colon cancer)
0,697  0,004  Antineoplastic (squamous cell carcinoma)
0,696  0,013  Antileukemic
0,686  0,004  P-glycoprotein inhibitor
0,687  0,007  Antineoplastic (melanoma)
0,681  0,008  Antineoplastic (cervical cancer)
0,672  0,004  Hepatoprotectant
0,667  0,005  Antineoplastic (brain cancer)
0,654  0,005  Antimitotic
0,644  0,009  Antioxidant
0,641  0,008  Hepatic disorders treatment
0,629  0,009  CYP2C9 inhibitor
0,629  0,012  Chemopreventive
0,623  0,009  Antineoplastic (non-small cell lung cancer)
0,609  0,008  Free radical scavenger
0,604  0,008  Antineoplastic (glioma)
0,606  0,012  Spasmolytic
0,599  0,008  Vasodilator, coronary
0,596  0,008  Antineoplastic (multiple myeloma)
0,586  0,007  Antineoplastic enhancer
0,576  0,004  Acetylcholinesterase inhibitor
0,585  0,016  5 Hydroxytryptamine release stimulant
0,584  0,018  Antihypercholesterolemic
0,561  0,008  Antineoplastic (glioblastoma multiforme)
0,559  0,007  CYP3A4 inhibitor
0,556  0,006  Antineoplastic (renal cancer)
0,554  0,005  Topoisomerase II inhibitor
0,560  0,017  CYP1A2 substrate
0,548  0,010  Amyloid beta aggregation inhibitor
0,551  0,015  AR expression inhibitor
0,549  0,017  12-Lipoxygenase inhibitor
0,544  0,016  GABA C receptor rho-3 antagonist
0,552  0,031  15-Lipoxygenase inhibitor
0,541  0,029  CYP2C9 substrate
0,529  0,019  CTGF expression inhibitor
0,515  0,010  Antimutagenic
0,509  0,005  Cholinergic
0,527  0,025  5 Hydroxytryptamine release inhibitor
0,518  0,017  Lipoxygenase inhibitor
0,510  0,011  Antineoplastic (lymphoma)
0,504  0,013  DNA damaging
0,509  0,019  Apoptosis antagonist
0,478  0,006  Amylase inhibitor
0,488  0,016  Hypoxia-inducible factor 1 alpha inhibitor
0,475  0,004  CYP2B6 inhibitor
0,484  0,013  Vasodilator
0,512  0,043  TNF expression inhibitor
0,477  0,015  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,465  0,008  Melanin inhibitor
0,480  0,023  Antineoplastic (pancreatic cancer)
0,528  0,072  Alpha-glucosidase inhibitor
0,478  0,030  Antineoplastic (ovarian cancer)
0,452  0,012  Antineoplastic (small cell lung cancer)
0,442  0,005  Butyrylcholinesterase inhibitor
0,482  0,047  Transcription factor NF kappa B inhibitor
0,448  0,016  Antineoplastic (liver cancer)
0,427  0,005  NADPH oxidase inhibitor
0,444  0,030  Radioprotector
0,424  0,010  MAO inhibitor
0,434  0,022  Nitric oxide antagonist
0,460  0,049  CYP3A4 substrate
0,428  0,022  Dyrk kinase inhibitor
0,430  0,025  Antiprotozoal (Leishmania)
0,428  0,030  Carcinogenic
0,406  0,008  MAO A inhibitor
0,414  0,017  Antineoplastic (lymphocytic leukemia)
0,412  0,020  Antihypertriglyceridemic
0,415  0,025  Antipyretic
0,398  0,008  Liver fibrosis treatment
0,444  0,055  Prostaglandin dehydrogenase inhibitor
0,401  0,020  Pyruvate kinase inhibitor
0,394  0,019  RNA-directed DNA polymerase inhibitor
0,376  0,005  Topoisomerase II alpha inhibitor
0,404  0,033  Cytostatic
0,404  0,034  UGT1A9 substrate
0,405  0,037  Cardioprotectant
0,368  0,007  Topoisomerase I inhibitor
0,365  0,005  CDC-like kinase 1 inhibitor
0,389  0,031  Mutagenic
0,383  0,025  Antineoplastic (osteosarcoma)
0,379  0,030  Cardiodepressant
0,378  0,033  Proliferative diseases treatment
0,372  0,032  Antihypoxic
0,345  0,007  Carcinogenic, group 1
0,385  0,049  Aldehyde oxidase inhibitor
0,346  0,013  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,338  0,014  Genotoxic
0,430  0,108  DNA polymerase beta inhibitor
0,346  0,025  GST M1-1 substrate
0,321  0,004  Multidrug resistance-associated protein 1 inhibitor
0,408  0,091  Alzheimer's disease treatment
0,321  0,004  Alpha tubulin antagonist
0,360  0,047  CYP2D6 inhibitor
0,321  0,011  MAO B inhibitor
0,314  0,005  Phobic disorders treatment
0,318  0,016  Lipid peroxidase inhibitor
0,287  0,004  Papain-like protease (SARS coronavirus) inhibitor
0,287  0,009  Antihemorrhagic
0,291  0,019  UGT2B15 substrate
0,283  0,011  Cystathionine beta-synthase inhibitor
0,273  0,008  GABA C receptor rho-2 antagonist
0,272  0,008  Histidine decarboxylase inhibitor
0,323  0,064  NOS3 expression inhibitor
0,260  0,005  Beta tubulin antagonist
0,280  0,032  VCAM1 expression inhibitor
0,260  0,017  LDLR expression enhancer
0,280  0,037  UGT1A1 substrate
0,289  0,047  Antineoplastic (sarcoma)
0,288  0,047  UGT1A6 substrate
0,369  0,129  DNA directed DNA polymerase inhibitor
0,285  0,047  Psychostimulant
0,294  0,056  Tumour necrosis factor alpha release inhibitor
0,315  0,080  Bone diseases treatment
0,259  0,025  Skin whitener
0,237  0,005  CDC-like kinase 3 inhibitor
0,286  0,056  Antiamyloidogenic
0,262  0,032  Neurotrophic factor enhancer
0,238  0,015  Interleukin 4 antagonist
0,288  0,072  Antiosteoporotic
0,218  0,005  Phosphodiesterase V inhibitor
0,221  0,009  Antineoplastic alkaloid
0,249  0,039  Male reproductive disfunction treatment
0,239  0,029  Carcinogenic, group 3
0,294  0,085  CYP2D6 substrate
0,242  0,034  Acaricide
0,270  0,062  Sensitization
0,215  0,008  Carcinogenic, group 2A
0,318  0,111  Antiprotozoal
0,270  0,064  5 Hydroxytryptamine uptake stimulant
0,255  0,053  Clk dual-specificity kinase inhibitor
0,278  0,076  CYP2C19 substrate
0,332  0,131  Calcium channel L-type activator
0,266  0,067  Hypoglycemic
0,239  0,040  Nitric-oxide synthase stimulant
0,244  0,045  Non-steroidal antiinflammatory agent
0,303  0,106  Ulceration
0,247  0,050  Platelet adhesion inhibitor
0,201  0,006  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,231  0,036  UGT1A3 substrate
0,243  0,049  Peroxidase inhibitor
0,239  0,044  Dual specificity phosphatase 3 inhibitor
0,216  0,022  DNA intercalator
0,253  0,059  Antiparasitic
0,224  0,032  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,200  0,009  DNA repair enzyme inhibitor
0,233  0,042  Dual specificity phosphatase inhibitor
0,257  0,067  5 Hydroxytryptamine 1E antagonist
0,268  0,078  UGT2B4 substrate
0,202  0,013  Calcium antagonist
0,216  0,029  Monophenol monooxygenase inhibitor
0,219  0,033  VEGF expression inhibitor
0,261  0,076  Chemoprotective
0,192  0,008  DOPA decarboxylase inhibitor
0,191  0,006  Phosphodiesterase 5A inhibitor
0,222  0,039  Antineoplastic (gastric cancer)
0,218  0,036  Protein kinase stimulant
0,206  0,028  SULT1A3 substrate
0,185  0,009  CYP2A6 inhibitor
0,240  0,068  Cyclic AMP phosphodiesterase inhibitor
0,185  0,014  Antineoplastic (uterine cancer)
0,177  0,006  Phosphodiesterase XI inhibitor
0,177  0,006  Phosphodiesterase 11A inhibitor
0,218  0,048  Muscle relaxant
0,191  0,022  Microtubule formation inhibitor
0,227  0,058  Antiviral (Influenza)
0,275  0,106  ICAM1 expression inhibitor
0,190  0,022  Cyclooxygenase 3 inhibitor
0,212  0,045  3C-like protease (Human coronavirus) inhibitor
0,211  0,046  5 Hydroxytryptamine 3E antagonist
0,311  0,149  Transcription factor inhibitor
0,170  0,009  Aldose reductase inhibitor
0,164  0,004  Potassium channel Kv1.3 blocker
0,239  0,082  Superoxide dismutase inhibitor
0,295  0,139  Antibacterial
0,274  0,118  Antiprotozoal (Plasmodium)
0,158  0,004  Endothelin receptor antagonist
0,212  0,062  Antihelmintic
0,175  0,026  Xanthine oxidase inhibitor
0,168  0,019  Heat shock protein 70 antagonist
0,212  0,064  Abortion inducer
0,184  0,038  Antifungal enhancer
0,195  0,049  Antiviral (Herpes)
0,237  0,092  Antineoplastic (bladder cancer)
0,231  0,088  Vascular (periferal) disease treatment
0,170  0,030  Carcinogenic, group 2B
0,206  0,068  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,220  0,082  Antihypotensive
0,158  0,021  Creatine kinase inhibitor
0,171  0,034  Antitussive
0,139  0,004  Glutamate (mGluR7) antagonist
0,147  0,017  Antiviral (SARS coronavirus)
0,147  0,017  Antiviral (Coronavirus)
0,178  0,048  Skeletal muscle relaxant
0,151  0,021  GABA C receptor rho-1 antagonist
0,323  0,194  Antiinflammatory
0,141  0,013  Postmenopausal disorders treatment
0,183  0,055  ATPase inhibitor
0,174  0,046  Cyclooxygenase 1 inhibitor
0,179  0,056  Protein-tyrosine phosphatase inhibitor
0,160  0,041  Antiviral (Hepatitis B)
0,159  0,040  Antihelmintic (Trematoda)
0,232  0,114  Streptokinase A inhibitor
0,121  0,004  Endothelin B receptor antagonist
0,229  0,113  Respiratory analeptic
0,134  0,017  Cyclin B3 inhibitor
0,144  0,029  Sphingosine 1-phosphate receptor 2 agonist
0,179  0,063  Antineoplastic (bone cancer)
0,131  0,015  Myeloperoxidase inhibitor
0,209  0,095  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,147  0,034  Choleretic
0,148  0,036  SULT1A1 substrate
0,245  0,133  FMO1 substrate
0,179  0,068  Tumour necrosis factor antagonist
0,164  0,054  Mannose-6-phosphate isomerase inhibitor
0,164  0,054  Antiprotozoal (Coccidial)
0,171  0,062  Cystic fibrosis treatment
0,190  0,082  Cytotoxic
0,157  0,050  Antiseptic
0,120  0,014  Antiviral (Hepatitis A)
0,190  0,084  Pneumotoxic
0,144  0,038  Antiviral (Papilloma)
0,109  0,004  Endothelin A receptor antagonist
0,149  0,047  Alkylator
0,127  0,026  NAD(P)H dehydrogenase (quinone) inhibitor
0,103  0,004  Ryanodine receptor antagonist
0,118  0,019  mTOR complex 2 inhibitor
0,209  0,110  DNA synthesis inhibitor
0,102  0,005  Acetyl-CoA transferase 2 inhibitor
0,155  0,059  Erectile dysfunction treatment
0,160  0,065  Heat shock protein 90 antagonist
0,148  0,055  Cyclooxygenase 2 inhibitor
0,097  0,004  Dopamine autoreceptor agonist
0,122  0,030  Estrogen receptor beta antagonist
0,156  0,065  Cyclooxygenase inhibitor
0,119  0,030  Carbonic anhydrase VI inhibitor
0,205  0,117  Antiprotozoal (Trypanosoma)
0,126  0,039  Dementia treatment
0,146  0,060  Psychosexual dysfunction treatment
0,211  0,127  Radiosensitizer
0,123  0,039  Sphingomyelinase inhibitor
0,125  0,041  Electron transport complex I inhibitor
0,121  0,038  Vascular dementia treatment
0,150  0,068  Hemostatic
0,124  0,042  Beta glucuronidase inhibitor
0,215  0,136  Antifungal
0,125  0,047  Estrogen antagonist
0,094  0,016  Protease activated receptor antagonist
0,136  0,060  Antibacterial (Helicobacter pylori)
0,164  0,089  Succinate dehydrogenase inhibitor
0,159  0,085  UGT2B10 substrate
0,094  0,021  Antitreponemal
0,101  0,028  Thioredoxin reductase inhibitor
0,168  0,096  Anesthetic general
0,078  0,007  GABA B receptor antagonist
0,102  0,032  Telomerase inhibitor
0,097  0,029  CDC25A inhibitor
0,089  0,021  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,126  0,059  Protein-tyrosine phosphatase 1B inhibitor
0,240  0,174  Antipruritic, allergic
0,118  0,054  GABA C receptor antagonist
0,143  0,080  Antiviral (Influenza A)
0,085  0,022  Xanthine dehydrogenase inhibitor
0,090  0,028  Phosphodiesterase VI inhibitor
0,127  0,064  Aldehyde dehydrogenase inhibitor
0,098  0,036  Macrophage migration inhibitory factor inhibitor
0,105  0,043  SULT1E1 substrate
0,114  0,054  Alpha 2c adrenoreceptor antagonist
0,083  0,024  Aryl hydrocarbon receptor antagonist
0,098  0,039  Carbonic anhydrase XIII inhibitor
0,073  0,015  Topoisomerase II beta inhibitor
0,096  0,040  Inducible nitric-oxide synthase inhibitor
0,169  0,116  Antiparkinsonian, rigidity relieving
0,152  0,099  CDC-like kinase 4 inhibitor
0,089  0,037  Glutamate decarboxylase inhibitor
0,098  0,046  Ornithine decarboxylase inhibitor
0,095  0,046  ATPase (Vacuolar H+) inhibitor
0,127  0,079  Alkaline phosphatase inhibitor
0,107  0,059  Carbonic anhydrase XV inhibitor
0,155  0,108  UDP-glucuronosyltransferase substrate
0,090  0,044  D-Ala-D-Ala ligase inhibitor
0,086  0,040  Estrogen receptor alpha antagonist
0,150  0,105  Sedative
0,105  0,060  5-Lipoxygenase inhibitor
0,071  0,028  Transcription factor RelA inhibitor
0,138  0,095  UGT1A4 substrate
0,134  0,092  Adenylate cyclase stimulant
0,072  0,031  Neuraminidase inhibitor
0,100  0,060  Nitric-oxide synthase inhibitor
0,057  0,017  DNA-dependent protein kinase inhibitor
0,059  0,019  Adenylate cyclase 1 inhibitor
0,083  0,045  Keratolytic
0,115  0,077  Antifungal (Pneumocystis)
0,058  0,023  CD45 antagonist
0,158  0,123  Insulin sensitizer
0,056  0,023  Factor III inhibitor
0,085  0,054  Antineoplastic antibiotic
0,055  0,023  Carbonic anhydrase VII inhibitor
0,107  0,076  Photosensitizer
0,131  0,101  UGT2B9 substrate
0,098  0,069  Urease inhibitor
0,113  0,084  Antiviral (Influenza B)
0,117  0,089  Bone formation stimulant
0,065  0,038  Aromatase inhibitor
0,049  0,023  Phosphodiesterase 6C inhibitor
0,059  0,035  Postcoital contraceptive
0,083  0,059  Phosphodiesterase IV inhibitor
0,118  0,096  Antiparkinsonian, tremor relieving
0,091  0,073  Carbonic anhydrase III inhibitor
0,148  0,131  Antirickettsial
0,026  0,010  Monocarboxylic acid transporter inhibitor
0,026  0,010  Monocarboxylic acid transporter 1 inhibitor
0,095  0,079  Alpha 2b adrenoreceptor antagonist
0,090  0,075  Phosphodiesterase 6D inhibitor
0,067  0,052  Elastase 1 inhibitor
0,086  0,072  Uric acid excretion stimulant
0,128  0,114  Heat shock protein 90 alpha antagonist
0,248  0,235  MAP kinase 1 inhibitor
0,051  0,039  Acetyl-CoA transferase inhibitor
0,065  0,057  Exportin-1 inhibitor
0,087  0,082  Sulfotransferase substrate
0,210  0,206  Antineoplastic (non-Hodgkin's lymphoma)
0,042  0,038  Neuraminidase (Influenza A) inhibitor
0,064  0,060  Anticholelithogenic
0,118  0,115  UGT2B7 substrate
0,126  0,122  Uterine stimulant
0,029  0,027  Nucleoside transporters inhibitor
0,058  0,058  Neuraminidase (influenza) inhibitor
0,118  0,118  NOS3 expression enhancer

